Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least ...

For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban ...

or 10 mg (5 mg twice daily; the full-dose group) of apixaban for an additional 12 months. Neither patients nor their doctors knew which dose patients were receiving until the end of the trial.

twice daily and the full dose as 5 mg twice daily. Mahé and her colleagues randomly assigned 866 patients to take the reduced dose of Eliquis and 900 to take the full dose. All of the participants had ...

Eliquis (apixaban) is a brand-name prescription drug that’s prescribed for certain dangerous blood clots. Specifically, Eliquis is approved for use in adults to: Eliquis has boxed warnings.

Finally, MG also offers an Xpower edition with dual motors that comes with greatly increased power but a reduced 245-mile range. While it’s unclear if the new MG4 will be available under three named ...

The drug, tested on mice, restored these gamma oscillations, and in turn reconnected neurons to essentially heal the brain damage without arduous physical rehabilitation.

JSW MG Motor India has launched the MG Comet EV 2025. While the electric car can be bought at a starting price of Rs 7 lakh (ex-showroom), the battery-as-a-service (BaaS) model allows you to have it ...